Professor Peter Zandstra (IBBME) has been recognized by Engineering Conferences International with this year’s Scale-Up and Manufacturing of Cell-Based Therapies Award. The award acknowledges outstanding contributions to the development and commercialization of stem cell-based therapies.

Zandstra is internationally renowned for his work in integrating engineering and biological approaches for the design and development of stem cell technologies. Most notably, he is known for his contributions to the fundamental understanding of stem cell bioreactor technologies and establishing the conditions that effectively yield stem cell proliferation and differentiation. His work at U of T has also included approaches to examine physiological and therapeutic effects of these stem cells, which have tremendous potential to impact regenerative medicine and drug development for a range of diseases, including cancer and heart disease.

Continue reading at UofT Engineering News.